Delivery of drug nanoparticles and methods of use thereof
US11331278B2 · kind B2 · utility
0Cited by
52References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 2020 |
| Grant date | May 17, 2022 |
| Priority date | — |
| Expiry date | Dec 4, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A hydrophobic topical skin composition is disclosed. The composition includes greater than 50% w/w of the composition of a continuous hydrophobic carrier, 5-24% w/w of one or more volatile silicone fluids, and 0.1 to 5% w/w of the composition of a plurality of taxane nanoparticles, wherein the mean particle size (number) of the taxane nanoparticles is from 0.1 microns to 1.5 microns, and wherein the taxane nanoparticles are crystalline nanoparticles or a combination of amorphous and crystalline nanoparticles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.